Sep 29, 2024, 15:21
Joe Y Chang: Intensity-modulated proton vs photon therapy with concurrent chemo in medical inoperable stage III NSCLC
Joe Y Chang, Professor and Director, Stereotactic Ablative Radiotherapy Program, MD Anderson Cancer Center, shared a post on X:
“MD Anderson finished all enrollment of phase II randomized study comparing intensity-modulated proton vs photon therapy with concurrent chemo in medical inoperable stage III NSCLC.
I am lucky enough to enroll the last pt and received a nice bottle of wine from Zhongxing Liao.”
Source: Joe Y Chang/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 22, 2024, 07:44
Dec 22, 2024, 07:35
Dec 22, 2024, 07:32
Dec 22, 2024, 07:25
Dec 22, 2024, 07:16
Dec 22, 2024, 07:01
Dec 22, 2024, 06:59
Dec 22, 2024, 06:56